NORDEA INVESTMENT MANAGEMENT AB
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1218210
STOCKHOLM, V7
Position in ARWR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$23,163,103
+$3,949,379 QoQ
Shares Held
284,175
-7.3% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#58
of 497 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $503,679,873 across 20 Biotechnology names. ARWR ranks #3 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
363,479 | $226,643,694 | |
| 2 | RPRX |
Royalty Pharma plc
|
2,576,772 | $144,479,604 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
284,175 | $23,163,103 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
49,943 | $15,786,482 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,496 | $15,148,278 | |
| 6 | EXEL |
Exelixis, Inc.
|
210,314 | $11,443,184 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
26,913 | $8,101,620 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
64,964 | $7,963,286 |
All Filings in ARWR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,163,103 | 284,175 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $19,213,724 | 306,439 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $21,527,023 | 324,251 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $12,840,005 | 372,282 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $3,370,851 | 213,345 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $1,667,308 | 130,872 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,485,133 | 132,188 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $2,409,859 | 124,412 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $3,370,097 | 129,669 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,386,010 | 153,357 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $4,778,251 | 156,152 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $4,298,904 | 159,989 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,708,096 | 160,070 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $3,158,642 | 124,356 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $5,100,987 | 125,764 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $4,390,395 | 132,841 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $4,717,400 | 133,979 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,986,051 | 108,416 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $7,116,509 | 107,338 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $6,717,218 | 107,596 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $6,141,517 | 74,155 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $495,600 | 7,474 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||